StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

tert-Butyl 4-(2-aminoethyl)piperazine-1-carboxylate → 4-(4-benzylphenylamino)-6-(2-(1-N-BOC-piperazin-4-yl)ethylamino)-1,7-naphthyridine-3-carbonitrile

HRID 2113565
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 2113565
[CH2:1]([C:8]1[CH:13]=[CH:12][C:11]([NH:14][C:15]2[C:24]3[C:19](=[CH:20][N:21]=[C:22](F)[CH:23]=3)[N:18]=[CH:17][C:16]=2[C:26]#[N:27])=[CH:10][CH:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[C:28]([N:35]1[CH2:40][CH2:39][N:38]([CH2:41][CH2:42][NH2:43])[CH2:37][CH2:36]1)([O:30][C:31]([CH3:34])([CH3:33])[CH3:32])=[O:29].FC1C=C2C(=NC=1)N=CC=C2.FC1C=CC2C(=NC=CC=2)N=1>C(Cl)Cl.CO.C1COCC1>[CH2:1]([C:8]1[CH:13]=[CH:12][C:11]([NH:14][C:15]2[C:24]3[C:19](=[CH:20][N:21]=[C:22]([NH:43][CH2:42][CH2:41][N:38]4[CH2:39][CH2:40][N:35]([C:28]([O:30][C:31]([CH3:34])([CH3:33])[CH3:32])=[O:29])[CH2:36][CH2:37]4)[CH:23]=3)[N:18]=[CH:17][C:16]=2[C:26]#[N:27])=[CH:10][CH:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

8

Edukt 4

HCID 1514400tert-Butyl 4-(2-aminoethyl)piperazine-1-carboxylateHCID 205311893-Fluoro-1,8-naphthyridineHCID 585467682-Fluoro-1,8-naphthyridineHCID 691852474-(4-Benzylphenylamino)-6-fluoro-1,7-naphthyridine-3-carbonitrile

Produkt 1

HCID 691837124-(4-benzylphenylamino)-6-(2-(1-N-BOC-piperazin-4-yl)ethylamino)-1,7-naphthyridine-3-carbonitrile
Ausbeute 23 %

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 887MethanolLösungsmittelHCID 6344DichloromethaneLösungsmittelHCID 8028TetrahydrofuranLösungsmittel

Versuchsvorschrift

A microwave vial was charged with 4-(4-benzylphenylamino)-6-fluoro-1,7-naphthyridine-3-carbonitrile (0.100 g, 0.282 mmol), 1-N-BOC-4-(2-aminoethyl)piperazine and 2 mL THF, crimp-sealed, and heated in a microwave reactor at 180° C. for 35 minutes, until TLC analysis (5% MeOH in CH2Cl2) showed disappearance of the 6-fluoronaphthyridine. This process was repeated with 3 additional aliquots of the fluoronaphthyridine (0.120 g, 0.100 g, 0.100 g), and the contents of all 4 vials were then combined, partitioned between 50 mL each EtOAc and brine, and worked up as described above for the synthesis of WAY-191220. The crude product was purified by flash chromatography over silica gel (5% MeOH in CH2Cl2) and lyophilized to give pure 4-(4-benzylphenylamino)-6-(2-(1-N-BOC-piperazin-4-yl)ethylamino)-1,7-naphthyridine-3-carbonitrile (0.151 g, 23% yield): 1H NMR (400 MHz, DMSO-D6) δ 1.39 (s, 9 H) 2.34-2.44 (m, 4 H) 2.57 (t, J=6.6 Hz, 2 H) 3.21-3.42 (m, 6 H) 3.99 (s, 2 H) 6.59 (t, J=5.3 Hz, 1 H) 7.03 (s, 1 H) 7.14-7.34 (m, 9 H) 8.22 (s, 1 H) 8.81 (s, 1 H) 9.56 (s, 1 H).

Aufarbeitung

  1. customcrimp-sealed
  2. custompartitioned between 50 mL each EtOAc and brine
  3. customas described above for the synthesis of WAY-191220
  4. customThe crude product was purified by flash chromatography over silica gel (5% MeOH in CH2Cl2)

Quellen und Nachweise

ORD-Eintrag
ord-3cabb5c94809448d8e76e61cded7b693
Quelldatensatz
uspto-grants-2008_10
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US07432279B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion